Dolly Parton announced Monday that she is cancelling her planned Las Vegas residency, "Dolly: Live in Las Vegas" [1].
The cancellation marks a significant shift for the Grammy-winning singer, who had been preparing for a major return to the stage in one of the world's most prominent entertainment hubs [1, 2].
Parton shared the news via social media, explaining that the decision stems from ongoing health struggles. She said her immune system and digestive system "got all out of whack over the past couple of years" [4]. The singer is currently undergoing medical treatments and taking medication to address these issues [4, 5].
Despite the cancellation, Parton expressed optimism regarding her recovery. She said, "I'm responding really well to meds and treatments, and I'm improving everyday" [6].
The residency was scheduled to take place at The Colosseum at Caesar's Palace in Las Vegas, Nevada [3]. According to reports, the residency was originally slated to begin in September 2025 [3]. The project had been announced in June of the previous year [3].
Parton's health update is a rare disclosure of her private medical status. While she has not specified a particular diagnosis, she noted that the conditions are treatable, and that she is still in the process of healing [4].
Fans and industry peers have responded with support following the announcement. The singer's decision to prioritize health over the high-profile residency reflects the physical demands of performing in a Las Vegas venue, which often requires rigorous choreography and vocal stamina over multiple consecutive nights.
“My immune system and my digestive system got all out of whack over the past couple of years.”
The cancellation of a residency at The Colosseum highlights the precarious nature of high-stakes performance contracts for aging icons. By citing specific systemic health issues, Parton is managing public expectation and protecting her long-term wellness over immediate commercial gain in the US entertainment market.
